|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 13.858,00 GBX | +2,24% |
|
+0,41% | +0,49% |
| 07/06 | AstraZeneca looft resultaten fase 3-studie met remmer Ultomiris | AN |
| 07/06 | Bernstein ziet opwaarts potentieel in AstraZeneca's niet-oncologische pijplijn na 'fireside chat' | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | k/w-verhouding (N) | Koers-boekwaarde (N) | PEG (N) | EV/omzet (N) | Beurskap. / EBITDA (N) | Beurskap. / EBIT (N) | Dividendrendement (N) | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 23.42x | 5.41x | 1.12x | 4.85x | 13.81x | 14.45x | 1,8% | 288 mld. | |
| 33.11x | 19.76x | 0.68x | 12.04x | 24.78x | 25.27x | 0,6% | 1.009 mld. | |
| 24.88x | 6.26x | -1.64x | 5.74x | 15.6x | 17.25x | 2,29% | 560 mld. | |
| 27.82x | -827.16x | 0.11x | 6.77x | 13.84x | 14.22x | 3,02% | 401 mld. | |
| 17.55x | 6.47x | 1.08x | 4.34x | 10.65x | 12.11x | 3,07% | 328 mld. | |
| 20.62x | 6.16x | -172.85x | 5.32x | 12.95x | 14.12x | 3,06% | 272 mld. | |
| 12.56x | 5.5x | -6.76x | 4.71x | 9.62x | 11.3x | 4% | 194 mld. | |
| 22.73x | 16.95x | 2.81x | 6.08x | 10.62x | 13.92x | 2,89% | 189 mld. | |
| -46.22x | 8.77x | 0.33x | 5.58x | 31.48x | 62.73x | 2,51% | 160 mld. | |
| 12.18x | 1.69x | 0.21x | 3.19x | 7.76x | 9.34x | 6,73% | 148 mld. | |
| 11.22x | 4.97x | 0.24x | 3.08x | 8.22x | 8.93x | 4,39% | 117 mld. | |
| 25.55x | 5.13x | 1.8x | 7.72x | 17.4x | 18.12x | -.--% | 113 mld. | |
| 11.39x | 1.24x | 1.65x | 2.25x | 7.34x | 8.14x | 5,5% | 108 mld. | |
| 12.42x | 4.26x | 1.18x | 2.66x | 7.82x | 8.78x | 3,61% | 103 mld. | |
| 24.33x | 5.54x | 1.37x | 8.3x | 15.68x | 16.4x | 1,81% | 77,57 mld. | |
| 43.84x | 1.09x | 0.68x | 2.59x | 9.55x | 27.07x | 4,06% | 48,56 mld. | |
| 33.47x | 4.52x | 1.74x | 7.41x | 24.62x | 27.92x | 0,58% | 46,02 mld. | |
| 15.47x | 1.26x | -0.09x | 1.48x | 7.01x | 11.7x | 0,61% | 41,02 mld. | |
| 39.59x | 19.03x | 0.17x | 6.69x | 29x | 29.09x | -.--% | 40,46 mld. | |
| 17.59x | 1.75x | 4.97x | 3.23x | 12.18x | 13.65x | 2,36% | 39,94 mld. | |
| Gemiddelde | 19,18x | -35,07x | -8,06x | 5,20x | 14,50x | 18,23x | 2,64% | 214,27 mld. | |
| Gewogen gemiddelde per kap. | 21,69x | -68,61x | -10,79x | 6,79x | 16,25x | 18,68x | 2,37% |
- Beurs
- Aandelen
- Koers AZN
- Sector AstraZeneca PLC
- Sectorale waarderingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
